dragon pharma ipamorelin Aerosol nasal Ipamorelin, 5 mg,

Injections are more frequent because of improved absorption and bioavailability

Batch: GF112025092 Key analytical results include: BPC-157 Assay Content: 15.51 mg BPC-157 Identification Retention Time: 0.997 TB-500 (Thymosin Beta-4) Assay Content: 15.41 mg TB-500 Identification Retention Time: 0.989 Bacterial Endotoxins: below 0.001 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium

It allows us to see what's happening at a much deeper level by properly assessing the risk of atherosclerosis and whether there is any developing insulin resistance playing a part

References: Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr. 2004;134(3):489-492. doi:10.1093/jn/134.3.489